Media Selangor

AstraZeneca’s experimental drug disappoints in breast cancer survival trial

DELAWARE, Sept 23 — AstraZeneca said today its experimental precision drug developed with Japan’s Daiichi Sankyo does not significantly improve overall survival for patients with a type of breast cancer in a late-stage trial.

Editor Selangor Journal

23 Sep 2024

About Us

Media Selangor Sdn Bhd, a subsidiary of the Selangor State Government (MBI), is a government media agency. In addition to Selangorkini and SelangorTV, the company also publishes portals and newspapers in Mandarin, Tamil and English.

Media Selangor Sdn. Bhd.

Level 11, Menara Bank Rakyat No. 1, Jalan Indah 14/8, Seksyen 14 40000 Shah Alam Selangor Darul Ehsan 03-5523 4856 03-5523 5856 www.mediaselangor.com.my